Delivery Order SPE2DR25D6038-SPE2DR26F95MF
Award Date 1/22/26
Potential Completion Date 1/23/26
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of CellCept 250 mg capsules (100 count units) with a ceiling value of $3,818.21. This is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,577.14 to AmerisourceBergen Drug Corp for the supply of CellCept 250 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,909.55 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 250 mg capsules (100-count units) with a ceiling value of $1,382.42. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count packages) valued at $7,746.68 under a firm fixed-price contract. The award was made on December 16, 2025, with an ultimate completion date of December 17, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for CellCept 500 mg tablets (500-count packages) valued at $12,029.30 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. CellCept (mycophenolate mofetil) is an...
- The Defense Logistics Agency awarded a delivery order valued at $18,356.53 to AmerisourceBergen Drug Corp for 500 tablets of CellCept 500 mg, an immunosuppressant medication commonly used in transplant and autoimmune disease management. The contract, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $12,027.50 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication used to prevent organ...
- The Defense Logistics Agency awarded a delivery order valued at $7,228.25 to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $9,754.64. This firm fixed-price delivery order, issued on August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The award was competitively awarded with no set-aside...